CORNOVUS PHARMACEUTICALS INC.
Small molecule therapies for heart failure
FARMINGTON, United States · Founded 2020
- Headquarters
- FARMINGTON, Connecticut
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Last Round
- GrantFeb 2014
- Rounds
- 1
About
Cornovus Pharmaceuticals develops small molecule therapies for advanced heart failure and cardiac hypertrophy. Founded by UConn Health's dean and cardiologist Dr. Bruce Liang, the company's lead compound delays the onset of heart failure following cardiac injury and is designed for cost-effective chemical manufacturing. The company operates out of UConn's Technology Incubation Program facility in Farmington, CT.
Summary
CORNOVUS PHARMACEUTICALS INC. is a Biotech company based in FARMINGTON, United States, founded in 2020. Its most recent funding was a Grant round in Feb 2014.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2014
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...